Joseph Jordan, CFO, discusses patient revenue, noting stability despite Medicare cuts. Sharon Vitti, CEO, addresses challenges in clinician retention and operational improvements boosting clinic productivity. Financial highlights for Q3 2024 include a 7.1% increase in net revenue to $190 million.